Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster infections — De Clercq Erik (1980) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster infections
Shared by
De Clercq Erik
KU Leuven
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster infections
Article
1980
en
Authors
+4 more
De Clercq Erik
KU Leuven
HD
H. Degreef
JW
J. Wildiers
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1980
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
De Clercq Erik
,
H. Degreef
,
J. Wildiers
,
Gabriela de Jonge
,
A Drochmans
,
J Descamps
,
P. De Somer
Article
1984
Oral (E)-5-(2-Bromovinyl)-2′-Deoxyuridine treatment of severe herpes zoster in cancer patients
J. Wildiers
,
De Clercq Erik
Article
1979
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
De Clercq Erik
,
J Descamps
,
P. De Somer
,
P J Barr
,
A. S. JONES
,
Richard Walker
Article
1980
(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis
P. C. Maudgal
,
De Clercq Erik
,
J Descamps
,
L Missotten
,
P. De Somer
,
Roger Busson
,
H. Vanderhaeghe
,
G. VERHELST
,
Richard Walker
,
A. S. JONES
Article
2005
(E)‐5‐(2‐Bromovinyl)‐2′‐deoxyuridine (BVDU)
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.